1. Home
  2. RGLS vs FXNC Comparison

RGLS vs FXNC Comparison

Compare RGLS & FXNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGLS
  • FXNC
  • Stock Information
  • Founded
  • RGLS 2007
  • FXNC 1907
  • Country
  • RGLS United States
  • FXNC United States
  • Employees
  • RGLS N/A
  • FXNC N/A
  • Industry
  • RGLS Biotechnology: Pharmaceutical Preparations
  • FXNC Major Banks
  • Sector
  • RGLS Health Care
  • FXNC Finance
  • Exchange
  • RGLS Nasdaq
  • FXNC Nasdaq
  • Market Cap
  • RGLS 106.7M
  • FXNC 108.3M
  • IPO Year
  • RGLS 2012
  • FXNC N/A
  • Fundamental
  • Price
  • RGLS $1.48
  • FXNC $20.50
  • Analyst Decision
  • RGLS Strong Buy
  • FXNC Strong Buy
  • Analyst Count
  • RGLS 6
  • FXNC 1
  • Target Price
  • RGLS $10.33
  • FXNC $21.00
  • AVG Volume (30 Days)
  • RGLS 263.0K
  • FXNC 12.5K
  • Earning Date
  • RGLS 11-07-2024
  • FXNC 10-28-2024
  • Dividend Yield
  • RGLS N/A
  • FXNC 2.90%
  • EPS Growth
  • RGLS N/A
  • FXNC N/A
  • EPS
  • RGLS N/A
  • FXNC 1.26
  • Revenue
  • RGLS N/A
  • FXNC $49,190,000.00
  • Revenue This Year
  • RGLS N/A
  • FXNC N/A
  • Revenue Next Year
  • RGLS N/A
  • FXNC N/A
  • P/E Ratio
  • RGLS N/A
  • FXNC $16.28
  • Revenue Growth
  • RGLS N/A
  • FXNC N/A
  • 52 Week Low
  • RGLS $1.08
  • FXNC $14.50
  • 52 Week High
  • RGLS $3.79
  • FXNC $21.75
  • Technical
  • Relative Strength Index (RSI)
  • RGLS 44.54
  • FXNC 71.70
  • Support Level
  • RGLS $1.47
  • FXNC $18.25
  • Resistance Level
  • RGLS $1.65
  • FXNC $20.75
  • Average True Range (ATR)
  • RGLS 0.11
  • FXNC 0.45
  • MACD
  • RGLS -0.00
  • FXNC 0.20
  • Stochastic Oscillator
  • RGLS 15.79
  • FXNC 92.06

About RGLS Regulus Therapeutics Inc.

Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. The product candidate of the company is RGLS8429, an anti-miR next-generation oligonucleotide targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease (ADPKD), and is in Phase 1b clinical development.

About FXNC First National Corporation

First National Corp is a bank holding company of First Bank, which is a commercial bank. Its core offering includes loans, deposits, wealth management, and other products and services. Loan products and services include personal loans, residential mortgages, home equity loans, and commercial loans. Deposit products and services include checking and savings. The Bank's wealth management division offers estate planning, investment management of assets, retirement accounts, and estate settlement.

Share on Social Networks: